scholarly journals Fatty Acid Metabolic Remodeling During Type 2 Diabetes Remission After Bariatric Surgery

Diabetes ◽  
2017 ◽  
Vol 66 (11) ◽  
pp. 2743-2755 ◽  
Author(s):  
Thomas Grenier-Larouche ◽  
Anne-Marie Carreau ◽  
Alain Geloën ◽  
Frédérique Frisch ◽  
Laurent Biertho ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Fatty Acid ◽  
Diabetes Remission ◽  
Metabolic Remodeling ◽  
Type 2 Diabetes Remission

Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery

2020 ◽  
Vol 30 (9) ◽  
pp. 3536-3548 ◽  
Author(s):  
Naomi Davies ◽  
Justin M. O’Sullivan ◽  
Lindsay D. Plank ◽  
Rinki Murphy
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Diabetes Remission ◽  
Type 2 Diabetes Remission

scholarly journals New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”

2020 ◽  
Vol 9 (4) ◽  
pp. 1070
Author(s):  
Ana de Hollanda ◽  
Albert Lecube ◽  
Miguel Angel Rubio ◽  
Enric Sánchez ◽  
Núria Vilarrasa ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Diabetes Remission ◽  
Dynamic Responses ◽  
Type 2 Diabetes Remission

Almost one third of patients do not achieve type 2 diabetes remission after bariatric surgery or are unable to sustain this effect long term. Our objective was to delve further into the dynamic responses of diabetes after bariatric surgery and to evaluate the “time-within-remission range” as a variable of metabolic control. A descriptive cohort study was done using a computerised multicentre and multidisciplinary registry. All data were adjusted by propensity score. A total of 1186 subjects with a follow-up of 4.5 ± 2.5 years were included. Type of surgery, diabetes remission, recurrence of diabetes, “time-within-remission range” and key predictors of diabetes outcomes were assessed. All patients (70% women, 51.4 ± 9.2 years old, body mass index (BMI) 46.3 ± 6.9 kg/m2) underwent primary bariatric procedures. “Time-within-remission range” were 83.3% (33.3–91.6) after gastric bypass, 68.7% (7.1–87.5) after sleeve gastrectomy and 90% (83.3–92.8) after malabsorptive techniques (p < 0.001 for all). Duration of diabetes, baseline HbA1c and insulin treatment were significantly negatively correlated with the “time-within-remission range”. The association of bariatric techniques with “time-within-remission range”, using gastric bypass as a reference, were: odds ratio (OR) 3.70 (2.34–5.84), p < 0.001 for malabsorptive techniques and OR 0.55 (0.40–0.75), p < 0.001 for sleeve gastrectomy. Characteristics of type 2 diabetes powerfully influence the outcomes of bariatric surgery. The “time-within-remission range” unveils a superiority of gastric bypass compared to sleeve gastrectomy.

Type 2 diabetes remission rate after bariatric surgery in Hospital DIPRECA, CHILE

2016 ◽  
Vol 12 (7) ◽  
pp. S169
Author(s):  
Matias Sepulveda ◽  
Yudith Preiss ◽  
Francisca Muñoz ◽  
Munir Alamo
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Remission Rate ◽  
Diabetes Remission ◽  
Type 2 Diabetes Remission

Preoperative insulin therapy as a marker for type 2 diabetes remission in obese patients after bariatric surgery

2018 ◽  
Vol 14 (3) ◽  
pp. 332-337 ◽  
Author(s):  
Kamyar Hariri ◽  
Daniela Guevara ◽  
Anusha Jayaram ◽  
Subhash U. Kini ◽  
Daniel M. Herron ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Insulin Therapy ◽  
Diabetes Remission ◽  
Obese Patients ◽  
Type 2 Diabetes Remission

Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery

2017 ◽  
Vol 184 ◽  
pp. 35-44.e4 ◽  
Author(s):  
Miriam Ejarque ◽  
Marianne Borlaug ◽  
Nuria Vilarrasa ◽  
Bruno Martinez-Perez ◽  
Gemma Llauradó ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Bariatric Surgery ◽  
Diabetes Remission ◽  
Type 2 Diabetes Remission
Sign in / Sign up

Export Citation Format

Share Document